Ally Bridge Group »

Kura Oncology shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Kura Oncology (KURA) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Kura Oncology

Tip: Access up to 7 years of quarterly data

All positions including Kura Oncology held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kura Oncology by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.7M 294k 19.54
2024-06-30 $6.3M 307k 20.59
2024-03-31 $7.8M 365k 21.33

More positions owned by Ally Bridge Group

Soleno Therapeutics (SLNO)
Replimune Group Call Option (REPL)
Madrigal Pharmaceuticals (MDGL)
Compass Pathways Sponsored Ads (CMPS)
Atai Beckley Nv SHS (ATAI)
Ascendis Pharma A/s - Sponsored Adr (ASND)
Lenz Therapeutics (LENZ)
Taysha Gene Therapies Com Shs (TSHA)
Amylyx Pharmaceuticals (AMLX)
Eupraxia Pharmaceuticals (EPRX)
Praxis Precision Medicines I Com New Call Option (PRAX)
Monopar Therapeutics Com New (MNPR)
Arcutis Biotherapeutics (ARQT)
Mind Medicine Mindmed Com New (MNMD)
Tarsus Pharmaceuticals (TARS)

View all positions for Ally Bridge Group

Top funds holding Kura Oncology

BlackRock
BVF
Suvretta Capital Management
Vanguard Group
Armistice Capital
State Street Corporation
Prosight Management
Goldman Sachs Group
AQR Capital Management
Jacobs Levy Equity Management
Millennium Management
Geode Capital Management
Qube Research & Technologies
Alethea Capital Management
Dimensional Fund Advisors

View all funds holding Kura Oncology